Acrylamide

Acrylamide

SCHEMBL3834772

C=CC(=O)NC(CC)CS(=O)(=O)O.C=CC(N)=O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
LMNA P02545 2/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 1/20 0.34
FGFR4 P22455 1/20 0.34
ZDHHC20 Q5W0Z9 1/20 0.33
ZDHHC2 Q9UIJ5 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP8 P22894 1/20 0.33
CA9 Q16790 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32
GAA P10253 1/20 0.31
POLB P06746 1/20 0.30
TGM2 P21980 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28436971 0.94 TSHR (0.44) TSHRLMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL456287 0.94 TSHR (0.44) TSHRLMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL29085234 0.92 TSHR (0.42) TSHRLMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL28817694 0.92 TSHR (0.42) TSHRLMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL28817681 0.92 TSHR (0.42) TSHRLMNAHPGDSMN1; SMN2ALDH1A1
Ammonia Solution, Strong SCHEMBL31228316 0.92 TSHR (0.42) TSHRLMNAHPGDSMN1; SMN2ALDH1A1
Acrylamide SCHEMBL27863437 0.83 ZDHHC20 (0.44) TSHRZDHHC20ZDHHC2TGM2
SCHEMBL5170699 0.81 TSHR (0.56) TSHRLMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL20381429 0.81 TAS1R3 (0.44) TSHRALDH1A1ZDHHC20ZDHHC2TAS1R3
SCHEMBL2559046 0.81 TAS1R3 (0.44) TSHRALDH1A1ZDHHC20ZDHHC2TAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090041688-A1 Sunless tanning compositions comprising certain substituted polyamine compounds and methods of use DUEVA-KOGANOV OLGA 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090041688-A1 Sunless tanning compositions comprising certain substituted polyamine compounds and methods of use SRM, TYR, XPA TSHR 1961/4885LMNA 1091/4885HPGD 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.